Clinical experience in T cell deficient patients

Allergy, Asthma and Clinical Immunology

Volumn 6, Issue 1, 2010, Pages

  Cole, Theresa S ^a   Cant, Andrew J ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ATM PROTEIN; CD40 LIGAND; CELL DNA; COTRIMOXAZOLE; CYCLOSPORIN A; ETOPOSIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MENINGITIS VACCINE; NIBRIN; PROTEIN; PROTEIN KINASE ZAP 70; PURINE NUCLEOSIDE PHOSPHORYLASE; PYRIMETHAMINE PLUS SULFADOXINE; RITUXIMAB; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; SMARCAL1 PROTEIN; STEROID; T LYMPHOCYTE RECEPTOR; TETANUS TOXOID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ADENOSINE DEAMINASE DEFICIENCY; ANTIBIOTIC PROPHYLAXIS; ATAXIA TELANGIECTASIA; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; BACTERIAL MENINGITIS; BARE LYMPHOCYTE SYNDROME; BLEEDING; BRONCHIOLITIS; CANDIDIASIS; CARTILAGE HAIR HYPOPLASIA; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD40 LIGAND DEFICIENCY; CD8+ T LYMPHOCYTE; CHICKENPOX; CHONDRODYSPLASIA; CHROMOSOME DELETION 22Q11; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DIGEORGE SYNDROME; DNA REPAIR; DRUG MEGADOSE; DYSGAMMAGLOBULINEMIA; ECZEMA; GASTROINTESTINAL DISEASE; GENE MUTATION; GENE REARRANGEMENT; GENE THERAPY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENOMEGALY; HERPES SIMPLEX; HUMAN; HUMAN HERPESVIRUS 6; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNODEFICIENCY CENTROMERIC INSTABILITY AND FACIAL ANOMALY SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION RISK; IPEX SYNDROME; KARYOTYPING; KUPFFER CELL; LIVER DISEASE; LYMPHADENOPATHY; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; LYMPHOPROLIFERATIVE DISEASE; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS I DEFICIENCY; MOLLUSCUM CONTAGIOSUM; NIJMEGEN BREAKAGE SYNDROME; OMENN SYNDROME; PARAINFLUENZA VIRUS; PHENOTYPE; PSEUDOMONAS INFECTION; PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETICULAR DYSGENESIS; REVIEW; ROTAVIRUS; SCHIMKE IMMUNE OSSEOUS DYSPLASIA; SCHWACHMAN SYNDROME; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; SPLENECTOMY; STAPHYLOCOCCUS INFECTION; SYNDROME CHARGE; T LYMPHOCYTE; T LYMPHOCYTE IMMUNODEFICIENCY; THROMBOCYTE TRANSFUSION; THYMUS TRANSPLANTATION; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKED DISORDER; X LINKED LYMPHOPROLIFERATIVE SYNDROME;

EID: 82755168671     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-6-9     Document Type: Review

References (34)

1. Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency. Berrington JE, et al. Arch Dis Child 2000 82 144 7 10.1136/adc.82.2.144 10648370 (Pubitemid 30305710)
2. Purine Nucleoside Phosphorylase Deficiency. Markert ML, Immunodeficiency Reviews 1991 3 45-81 1931007
3. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Pannicke U, et al. Nature Genetics 2009 41 101 5 10.1038/ng.265 19043417
4. Advances in hematopoeitic stem cell transplantation for primary immunodeficiency. Gennery AR, Cant AJ, Immunol Allergy Clin North Am 2008 28 439-56 18424341
5. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Neven B, et al. Blood 2009 133 4114 24 10.1182/blood-2008-09-177923
6. Molecular genetics of the bare lymphocyte syndrome. Masternak K, et al. Rev Immunogenet 2000 2 267 82 11258423
7. Clinical course of patients with major histocompatibility complex class II deficiency. Saleem MA, et al. Arch Dis Child 2000 83 356 9 10.1136/adc.83.4.356 10999878
8. Defective expression of T cell CD40 ligand causes × linked immunodeficiency with hyper IgM. Korthäuer U, et al. Nature 1993 361 494 10.1038/361539a0 8429898 (Pubitemid 23055615)
9. Defects in class switch recombination. Notarangelo LD, et al. J Allergy Clin Immunol 2006 117 855 64 10.1016/j.jaci.2006.01.043 16630945 (Pubitemid 44313814)
10. Report of the ESID collaborative study on clinical features and molecular analysis of X-linked Hyper IgM syndrome (abstract). Toniati P, Savoldi G, Jones AM, European Society for Immunodeficiencies Newsletter 2002 suppl F9 40
11. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002. Gennery AR, et al. Blood 2004 103 1152 7 10.1182/blood-2003-06-2014 14525761 (Pubitemid 38129585)
12. Clinical course of patients with WASP gene mutations. Imai K, et al. Blood 2004 103 456 64 10.1182/blood-2003-05-1480 12969986 (Pubitemid 38140073)
13. The Wiskott-Aldrich syndrome. Ochs HD, Thrasher AJ, J Allergy Clin Immunol 2006 117 725 38 10.1016/j.jaci.2006.02.005 16630926 (Pubitemid 44313817)
14. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes. Ochs HD, Immunol Res 2009 44 84-8 19082760
15. Clinical spectrum of ataxia-telangiectasia in adulthood. Verhagen MM, et al. Neurology 2009 73 430 7 10.1212/WNL.0b013e3181af33bd 19535770
16. Nijmegen breakage syndrome: clinical manifestations of defective response to DNA double strand breaks. Digweed M, Sperling K, DNA repair 2004 3 1207 17 10.1016/j.dnarep.2004.03.004 15279809 (Pubitemid 38997964)
17. Successful SCT for Nijmegen breakage syndrome. Albert MH, et al. Bone Marrow Transplant 2010 45 622 6 10.1038/bmt.2009.207 19684627
18. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). Hagleitner MM, et al. J Med Genet 2008 45 93 9 10.1136/jmg.2007.053397 17893117 (Pubitemid 351252872)
19. Cartilage-hair hypoplasia: molecular basis and heterogenicity of the immunological phenotype. Notarangelo LD, Roifman CM, Giliani S, Curr Opin Allergy Clin Immunol 2008 8 534 9 10.1097/ACI.0b013e328310fe7d 18978468
20. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Boerkoel CF, et al. Eur J Pediatr 2000 159 1 7 10.1007/s004310050001 10653321 (Pubitemid 30120118)
21. Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Thomas SE, et al. Pediatr Transplant 2004 8 507 12 10.1111/j.1399-3046.2004.00208.x 15367289 (Pubitemid 39279023)
22. Shwachman-Diamond Syndrome: UK perspective. Hall D, Dale P, Dodge JA, Arch Dis Child 2006 91 521 4 10.1136/adc.2003.046151 16714727 (Pubitemid 43836109)
23. Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Rujkijyanont P, et al. Br J Haematol 2009 145 806 15 10.1111/j.1365-2141.2009. 07692.x 19438500
24. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. McLean-Tooke A, Spickett GP, Gennery AR, Scand J Immunol 2007 66 1 7 10.1111/j.1365-3083.2007.01949.x 17587340 (Pubitemid 46985514)
25. Immune constituition monitoring after PBMC transplantation in complete DiGeorge Syndrome: an eight year follow up. Daguinadau N, et al. Clin immunol 2008 128 164 71 10.1016/j.clim.2008.03.524 18515186
26. Immunologic reconstituition in 22q deletion (DiGeorge) syndrome. McGhee SA, Lloret MG, Stiehm ER, Immunol Res 2009 45 37 45 10.1007/s12026-009-8108-7 19238335
27. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Markert ML, et al. Blood 2007 109 4539 47 10.1182/blood-2006-10-048652 17284531 (Pubitemid 46743425)
28. CHARGE syndrome. Blake KD, Prasad C, Orphanet J Rare Dis 2006 1 34 10.1186/1750-1172-1-34 16959034
29. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anolmalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome. A comparison of immunologic and nonimmunologic phenotypic features. Jyonouchi S, et al. Pediatrics 2009 123 871 7 10.1542/peds.2008-3400 19403480
30. Primary Immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. Moraes-Vasconcelos D, et al. J clin Immunol 2008 28 suppl 1 11 19 10.1007/s10875-008-9176-5 18264745
31. Aire. Mathis D, Benoist C, Annu Rev immunol 2009 27 287 312 10.1146/annurev.immunol.25.022106.141532 19302042
32. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type 1. Husebye ES, et al. J Int Med 2009 265 514 29 10.1111/j.1365-2796.2009.02090.x
33. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: Forkhead box protein 3 mutations and lack of regulatory T cells. Torgerson TR, Ochs HD, J Allergy Clin Immunol 2007 120 744 50 10.1016/j.jaci.2007.08.044 17931557 (Pubitemid 47531861)
34. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Worth A, Thrasher AJ, Gaspar HB, Br J Haematol 2006 133 124 40 10.1111/j.1365-2141.2006.05993.x 16611303